Sleep disruption is one of the most common concerns people describe when they are struggling with depression. Trouble falling asleep, waking repeatedly during the night, waking too early, sleeping far more than usual, or getting enough hours without feeling rested can all make depression harder to manage.
The relationship also works in both directions. Depression can interfere with sleep, while persistent sleep disruption can worsen mood, concentration, emotional regulation, and daily functioning. For adults in Houston who feel caught in this pattern, it can be helpful to view sleep and depression as connected parts of the same clinical picture rather than separate problems.
How Depression Can Affect Sleep
Depression can affect nearly every aspect of sleep. Some people experience insomnia, including difficulty falling asleep, staying asleep, or returning to sleep after waking early. Others experience nonrestorative sleep, where they spend enough time in bed but still wake up exhausted. Excessive sleepiness or prolonged sleep can also occur.
These changes are not simply a matter of poor habits or insufficient discipline. Mood, stress response, sleep timing, physical health, medications, substance use, and other psychiatric conditions can all influence sleep. When depression is present, disrupted sleep may become one of the symptoms that has the greatest impact on work, relationships, concentration, and the ability to follow through with daily responsibilities.
Why the Cycle Can Be Hard to Break
Poor sleep can make it harder to cope with difficult emotions, manage stress, and maintain routines that support recovery. In turn, worsening depressive symptoms can make the next night’s sleep more difficult.
This does not mean that everyone with depression and insomnia needs the same treatment. Some people benefit from changes to medication, psychotherapy, behavioral sleep treatment, or evaluation for a separate sleep disorder. Others may need a more comprehensive assessment when depression has not improved with standard approaches.
At our Bellaire clinic, we look closely at the full pattern: the timing and quality of sleep, current medications, mood symptoms, anxiety, trauma history, medical concerns, and prior treatment response. That evaluation helps us determine whether sleep disruption is primarily part of depression, whether another condition may be contributing, or whether both need attention at the same time.
When Advanced Depression Treatment May Be Considered
For patients with depression that has not improved adequately with prior treatment, an individualized psychiatric evaluation may include discussion of additional options. These treatments are intended to address depression when clinically appropriate; they are not direct treatments for sleep problems alone.
IV Ketamine Infusion Therapy
IV ketamine infusion therapy may be considered for some adults with treatment-resistant depression after a careful review of diagnosis, treatment history, medications, medical considerations, and goals of care. Psychiatric use of IV ketamine is off-label.
Research suggests that ketamine can reduce depressive symptoms more quickly than many conventional antidepressant approaches for some patients, but the response is individual and may not be durable without an ongoing treatment plan. Improvement in depression may help sleep for some people, but it should not be presented as a guaranteed or primary sleep intervention.
SPRAVATO® Treatment
SPRAVATO® treatment is an FDA-approved esketamine nasal spray for adults with treatment-resistant depression. It may be used alone or with an oral antidepressant, depending on the patient’s clinical situation.
Because of important safety considerations, SPRAVATO® is administered under direct medical supervision through a restricted REMS program, with observation after treatment. For patients whose depression and sleep disruption have become closely connected, it may be one option to discuss during a comprehensive consultation. It is not appropriate for everyone, and treatment decisions should be based on a full psychiatric and medical review.
Deep TMS
Deep TMS is delivered by an FDA-cleared device for major depressive disorder in adults who have not achieved satisfactory improvement with prior antidepressant treatment in the current episode.
Deep TMS is not a sleep treatment. However, some research on noninvasive neurostimulation in people being treated for major depressive disorder has found improvements in sleep measures alongside improvement in depressive symptoms. Those findings do not mean sleep will improve for every patient, and they should not replace a complete evaluation of insomnia, hypersomnia, nightmares, or other sleep concerns.
Treating the Whole Picture
When depression and sleep disruption occur together, it is important not to assume that one simple adjustment will resolve both. Sleep may be affected by depression, anxiety, trauma-related symptoms, medication effects, alcohol or substance use, circadian rhythm disruption, chronic pain, or an independent sleep disorder.
We work to identify the factors that may be keeping the cycle going. Depending on the individual, that may include reviewing current treatment, discussing psychotherapy or behavioral strategies, considering whether a sleep-focused evaluation is needed, or exploring our treatment options for treatment-resistant depression.
The exhaustion that comes with poor sleep can also make it difficult to seek care in the first place. A clear evaluation and a realistic treatment plan can help patients move forward without treating their symptoms as a personal failure.
Frequently Asked Questions
Why does depression cause sleep problems?
Depression can affect the systems involved in sleep timing, stress regulation, energy, and emotional processing. Some people experience insomnia or early waking, while others sleep excessively or wake without feeling rested. Sleep problems can also worsen depressive symptoms, which is why both concerns deserve attention.
Can treating depression improve sleep?
It can. For some people, sleep improves as depressive symptoms improve. Others may need additional treatment specifically focused on insomnia, sleep timing, nightmares, medication effects, or another sleep-related condition. The right approach depends on the full clinical picture.
Is it safe to take sleep medications while undergoing ketamine treatment?
Safety depends on the specific medication, dose, medical history, and treatment plan. Do not start, stop, or change a sleep medication without discussing it with the clinician who prescribes it and the psychiatric team overseeing treatment.
Does Deep TMS help with sleep?
Deep TMS is used to treat depression, not as a primary treatment for sleep disorders. Some patients may notice sleep improvement as depressive symptoms improve, but results vary. Persistent or severe sleep concerns may require separate evaluation.
What sleep issues are common with treatment-resistant depression?
Common concerns can include difficulty falling asleep, waking during the night, early morning awakening, nonrestorative sleep, or sleeping excessively. Nightmares, significant daytime sleepiness, loud snoring, breathing pauses during sleep, or unusual nighttime behaviors should also be discussed with a qualified clinician.
Key Takeaways
- Depression and sleep disruption can reinforce each other, making both conditions harder to manage.
- Sleep concerns may include insomnia, early waking, nonrestorative sleep, or excessive sleep.
- A comprehensive evaluation can help identify whether depression, anxiety, trauma-related symptoms, medication effects, or another sleep condition may be contributing.
- IV ketamine is off-label for psychiatric use and is not a primary sleep treatment.
- SPRAVATO® is an FDA-approved treatment option for adults with treatment-resistant depression and is administered under REMS supervision.
- Deep TMS may be considered for qualifying patients with depression, but it is not a standalone treatment for sleep disorders.
Conclusion
The depression-sleep cycle can feel self-perpetuating: poor sleep makes the next day harder, and depression can make the next night more difficult. When standard treatment has not provided adequate relief, it may be worth taking a closer look at the full pattern rather than treating sleep and depression as unrelated concerns.
At our Bellaire clinic, we evaluate complex depressive symptoms with attention to sleep, treatment history, coexisting conditions, and daily functioning. To discuss your situation, contact us to request a consultation.
About Dr. Sandhya Prashad
Dr. Sandhya Prashad, M.D., is a board-certified psychiatrist and the founder and medical director of Sandhya J. Prashad, M.D., Houston Ketamine Therapeutics, and Houston TMS Therapeutics. Her practice focuses on treatment-resistant depression and interventional psychiatric care, including IV ketamine therapy, SPRAVATO®, Deep TMS, therapy services, and comprehensive psychiatric evaluation.
Works Cited
Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., & Martin, J. L. (2021). Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 17(2), 255–262. https://pmc.ncbi.nlm.nih.gov/articles/PMC7853203/
Fang, H., Tu, S., Sheng, J., & Shao, A. (2019). Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment. Journal of Cellular and Molecular Medicine, 23(4), 2324–2332. https://onlinelibrary.wiley.com/doi/abs/10.1111/jcmm.14170
Nikolin, S., Rodgers, A., Schwaab, A., Bahji, A., Zarate, C., Vázquez, G., & Loo, C. (2023). Ketamine for the treatment of major depression: A systematic review and meta-analysis. eClinicalMedicine, 62, 102127. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2823%2900304-8/fulltext
Qiao, M.-X., Yu, H., & Li, T. (2024). Non-invasive neurostimulation to improve sleep quality and depressive symptoms in patients with major depressive disorder: A meta-analysis of randomized controlled trials. Journal of Psychiatric Research, 176, 282–292. https://www.sciencedirect.com/science/article/abs/pii/S0022395624003509
U.S. Food and Drug Administration. (2013). Brainsway Deep TMS System: 510(k) summary (K122288). https://www.accessdata.fda.gov/cdrh_docs/pdf12/k122288.pdf
U.S. Food and Drug Administration. (2025). SPRAVATO® (esketamine) nasal spray: Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s019lbl.pdf
Medical Disclaimer
This blog is provided for educational purposes only and does not constitute medical advice. The information presented here is not intended to diagnose, treat, cure, or prevent any condition. Individual results vary, and the treatments described may not be appropriate for every patient. Please discuss your symptoms and treatment options with a qualified psychiatric provider before making any medical decisions. If you are experiencing a psychiatric emergency or are in crisis, please call 988 (Suicide and Crisis Lifeline) or go to your nearest emergency room.